Free Trial

Quanterix (QTRX) Competitors

Quanterix logo
$5.96 -0.04 (-0.58%)
As of 03:02 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

QTRX vs. SIBN, EYPT, AEHR, ALNT, TRNS, LAB, CTKB, SENS, QSI, and FEIM

Should you be buying Quanterix stock or one of its competitors? The main competitors of Quanterix include SiBone (SIBN), Eyepoint Pharmaceuticals (EYPT), Aehr Test Systems (AEHR), Allient (ALNT), Transcat (TRNS), Standard BioTools (LAB), Cytek Biosciences (CTKB), Senseonics (SENS), Quantum-Si (QSI), and Frequency Electronics (FEIM).

Quanterix vs. Its Competitors

Quanterix (NASDAQ:QTRX) and SiBone (NASDAQ:SIBN) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, profitability and analyst recommendations.

Quanterix currently has a consensus target price of $11.75, suggesting a potential upside of 96.98%. SiBone has a consensus target price of $23.67, suggesting a potential upside of 49.60%. Given Quanterix's higher possible upside, analysts plainly believe Quanterix is more favorable than SiBone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quanterix
1 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
SiBone
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Quanterix has a beta of 1.07, meaning that its stock price is 7% more volatile than the S&P 500. Comparatively, SiBone has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500.

SiBone has a net margin of -12.83% compared to Quanterix's net margin of -56.04%. SiBone's return on equity of -14.20% beat Quanterix's return on equity.

Company Net Margins Return on Equity Return on Assets
Quanterix-56.04% -18.41% -14.80%
SiBone -12.83%-14.20%-10.38%

SiBone has higher revenue and earnings than Quanterix. SiBone is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quanterix$137.42M2.02-$38.53M-$1.82-3.28
SiBone$167.18M4.08-$30.91M-$0.56-28.25

86.5% of Quanterix shares are held by institutional investors. Comparatively, 98.1% of SiBone shares are held by institutional investors. 6.8% of Quanterix shares are held by company insiders. Comparatively, 4.0% of SiBone shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, SiBone had 8 more articles in the media than Quanterix. MarketBeat recorded 10 mentions for SiBone and 2 mentions for Quanterix. Quanterix's average media sentiment score of 0.50 beat SiBone's score of 0.44 indicating that Quanterix is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Quanterix
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SiBone
4 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

SiBone beats Quanterix on 11 of the 16 factors compared between the two stocks.

Get Quanterix News Delivered to You Automatically

Sign up to receive the latest news and ratings for QTRX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QTRX vs. The Competition

MetricQuanterixMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$277.47M$10.41B$9.05B$10.58B
Dividend YieldN/A1.87%5.69%4.71%
P/E Ratio-3.2821.0585.8427.32
Price / Sales2.0234.64535.95201.92
Price / CashN/A25.4637.9261.55
Price / Book0.703.4613.026.76
Net Income-$38.53M$208.83M$3.30B$275.79M
7 Day Performance5.58%1.92%4.69%2.44%
1 Month Performance39.04%2.48%9.86%8.86%
1 Year Performance-47.63%-4.64%84.90%35.45%

Quanterix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QTRX
Quanterix
1.7835 of 5 stars
$5.97
-0.6%
$11.75
+97.0%
-47.6%$277.47M$137.42M-3.28460News Coverage
Positive News
Analyst Forecast
SIBN
SiBone
3.9574 of 5 stars
$14.49
-0.1%
$23.67
+63.3%
+13.1%$625.54M$167.18M-25.87350Positive News
Analyst Forecast
EYPT
Eyepoint Pharmaceuticals
1.2011 of 5 stars
$13.62
-0.8%
$26.86
+97.2%
+63.7%$946.37M$43.27M-5.08120News Coverage
Analyst Forecast
AEHR
Aehr Test Systems
1.6609 of 5 stars
$31.65
+2.0%
N/A+106.0%$929.64M$58.97M-243.4490News Coverage
Earnings Report
Analyst Downgrade
Gap Down
ALNT
Allient
2.6366 of 5 stars
$43.14
-1.3%
$35.00
-18.9%
+152.4%$741.09M$529.97M50.162,525Analyst Forecast
TRNS
Transcat
3.3608 of 5 stars
$70.82
-2.0%
$112.20
+58.4%
-40.6%$673.12M$278.42M49.521,245News Coverage
Analyst Upgrade
LAB
Standard BioTools
1.9921 of 5 stars
$1.32
-1.5%
$1.55
+17.4%
-26.7%$511.87M$174.43M-4.13620News Coverage
Positive News
Analyst Forecast
CTKB
Cytek Biosciences
2.4693 of 5 stars
$4.02
+1.3%
$5.60
+39.3%
-22.6%$505.08M$200.45M-80.40500News Coverage
Positive News
Analyst Upgrade
SENS
Senseonics
2.3349 of 5 stars
$0.57
+22.0%
$1.54
+172.1%
+37.5%$460.30M$25.47M-4.3590News Coverage
Gap Up
High Trading Volume
QSI
Quantum-Si
2.5029 of 5 stars
$1.81
+5.2%
$3.48
+92.0%
+111.4%$348.29M$3.06M-2.66150Analyst Forecast
FEIM
Frequency Electronics
2.0325 of 5 stars
$38.27
+9.6%
$43.00
+12.4%
+215.3%$340.35M$69.81M16.71200Positive News
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:QTRX) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners